# Compass Therapeutics, Inc.: Form 8-K, filed Jun 4, 2021

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2021-06-04
- Accepted by EDGAR: Jun 4, 2021, 07:57 ET
- Period: 2021-06-03
- Accession: 0001193125-21-182106
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000119312521182106/d175899d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000119312521182106/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000119312521182106/d175899d8k.htm

Filed Jun 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-182106. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
